paroxetine (Brisdelle)

Title: paroxetine (Brisdelle)Category: MedicationsCreated: 2/24/2015 12:00:00 AMLast Editorial Review: 7/8/2016 12:00:00 AM
Source: MedicineNet Menopause General - Category: Primary Care Source Type: news

Related Links:

ConclusionThe findings revealed the heterogeneity of sexual health among BC patients in China and may guide to identify the high-risk patients and enable early intervention.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
Publication date: Available online 8 October 2020Source: Physiology &BehaviorAuthor(s): Luzia Jaeger Hintze, Gary Goldfield, Ryan Séguin, Aleck Damphousse, Alexandre Riopel, Éric Doucet
Source: Physiology and Behavior - Category: Physiology Source Type: research
Authors: Cronin C, Hungerford C, Wilson RL Abstract Many women experience vasomotor, psychosocial, physical and sexual symptoms during their menopausal life-stage. Specifically, the psychosocial symptoms of menopause can include loss of confidence, issues with self-identity and body image, inattention and loss of memory, increased levels of stress, and a higher risk of developing anxiety and depression. In the workplace, such symptoms can impact the woman's capacity to perform to her optimal levels. Even so, many women do not seek help to manage their symptoms due to feelings of embarrassment, the possibility of ex...
Source: Issues in Mental Health Nursing - Category: Nursing Tags: Issues Ment Health Nurs Source Type: research
The current life expectancy of females in the United Kingdom is estimated to be 82.9 years [1], and the average age of menopause is 51 years [2]. Women in the UK therefore spend around one-third of their life in the menopausal state. The timing of menopause influences future health outcomes, such that an early age at menopause increases risk of bone fractures and cardiovascular diseases while an increased risk of breast, ovarian and endometrial cancer have been associated with a late onset of menopause [3].
Source: Maturitas - Category: Primary Care Authors: Source Type: research
This study aimed to investigate the associations between total and subclasses of flavonoid and breast cancer risk among Chinese population. This case-control study recruited 1522 eligible breast cancer cases and 1547 frequency-matched control subjects from June 2007 to July 2018 in Guangdong, China. Dietary intake was obtained by face-to-face interview using a validated food frequency questionnaire. Odds ratios and 95% confidence intervals were calculated by multivariable logistic regression models. After adjusting for potential confounders, inverse associations were observed between total flavonoids, anthocyanidins, proan...
Source: European Journal of Cancer Prevention - Category: Cancer & Oncology Tags: Breast cancer Source Type: research
(The North American Menopause Society (NAMS)) CLEVELAND, Ohio --No one knows for sure how long they will live. A new study, however, suggests that leukocyte telomere length may offer some key insights into a woman's longevity and further demonstrates how maternal age at birth of last child affects telomere length and long-term health. Study results are published online today inMenopause, the journal of The North American Menopause Society (NAMS).
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Abstract The health benefits and risks of menopausal hormone therapy among women aged 50-59 years are examined in the Women's Health Initiative randomized, placebo-controlled trials using long-term follow-up data and a parsimonious statistical model that leverages data from older participants to increase precision. These trials enrolled 27,347 healthy post-menopausal women aged 50-79 at 40 U.S. clinical centers during 1993-1998, including 10,739 post-hysterectomy participants in a trial of conjugated equine estrogens, and 16,608 participants with uterus in the trial of these estrogens plus medroxyprogesterone acet...
Source: Am J Epidemiol - Category: Epidemiology Authors: Tags: Am J Epidemiol Source Type: research
ConclusionIn peri-menopausal and menopausal women, the risks and benefits of chronic NF therapy  should be weighed by the clinician and patient prior to prescribing long term NF. Patients must be educated about the potential NF toxicities and clinically monitored for signs and symptoms of potential adverse events while on chronic NF therapy.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
Cancer treatments can be damaging to the ovary, with implications for future fertility and reproductive lifespan. There is therefore a need for a biomarker than can usefully provide an assessment of the ovary and its potential for long-term function after cancer treatment, and ideally also be of value pre-treatment, for the prediction of post-treatment function. In this review we assess the value of anti-Müllerian hormone (AMH) in this context. Measurement of AMH at the time of cancer diagnosis has been shown to be predictive of whether or not there will remain some ovarian function post-treatment in women with breast...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
Authors: Piek MW, Postma EL, van Leeuwaarde R, de Boer JP, Bos AME, Lok C, Stokkel M, Filipe M, van der Ploeg IMC Abstract Introduction Thyroid cancer is one of the most common carcinomas diagnosed in adolescents and young adults (AYA), with a rapidly rising incidence over the past three decades. Surgery is the standard treatment for patients with differentiated thyroid carcinoma (DTC), and when indicated, followed by radioactive iodine (RAI) treatment. The aim of this study was to evaluate the possible effects of RAI therapy on ovarian function and fertility in women. Methods The PubMed, Embase and Web of Science ...
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research
More News: Men | Menopause | Paroxetine | Paxil | Primary Care